Social Media Best Practices for Marketing Medical Devices
Interview with Dr. Mukesh Kumar
Did you know the FDA recently issued a multi-million dollar contract to a private company that will be charged with monitoring social media? Yes, multi-million. Needless to say, that’s a significant amount of money.
Although many would argue the FDA has not been very clear regarding its guidance towards social media, you can’t deny that the FDA is beginning to take social media more serious than it ever has.
In this interview with Dr. Mukesh Kumar, Senior Director of Regulatory Affairs for Amarex Clinical Research, we’ll discuss common issues, misconceptions, and possible solutions in regards to using social media to market and sell FDA-regulated medical devices.
Interview Highlights with Dr. Mukesh Kumar
Why one particular company received a warning letter from the FDA for clicking the Facebook “Like” button.
Trends and recent discussions regarding the FDA’s overview and enforcement of social media as it pertains to marketing medical devices.
Risks and benefits: FDA guidance documents regarding the distribution of information via social media.
Best practices for managing social media within the medical device space.
If a patient submits a question regarding a medical device via Twitter, how is it possible to present balanced information given the 140-character limit?
If unidentified patients post comments regarding adverse events on a website not controlled by the medical device company, is that company required to report the event to FDA or attempt to contact the patient?
You May Like These Articles
Medsider Premium
Become a premium member and unlock access to exclusive Medsider benefits.
